CUAMC
LXRX icon

China Universal Asset Management Company’s Lexicon Pharmaceuticals LXRX Stock Holding History

China Universal Asset Management Company’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-63,698
Closed -$86K – 516
2025
Q3 		$86K Sell
63,698
-9,245
-13% -$10.5K 0.01% 399
2025
Q2 		$69K Buy
72,943
+434
+0.6% +$281 0.01% 393
2025
Q1 		$33.4K Sell
72,509
-4,141
-5% -$2.61K ﹤0.01% 441
2024
Q4 		$56.6K Buy
76,650
+7,123
+10% +$8.59K 0.01% 444
2024
Q3 		$109K Buy
69,527
+27,058
+64% +$48.2K 0.01% 351
2024
Q2 		$71.3K Sell
42,469
-4,461
-10% -$8K 0.01% 325
2024
Q1 		$113K Buy
46,930
+18,601
+66% +$40K 0.01% 363
2023
Q4 		$43.3K Buy
28,329
+22,043
+351% +$26.2K 0.01% 381
2023
Q3 		$6.85K Buy
6,286
+3,801
+153% +$6.67K ﹤0.01% 370
2023
Q2 		$5.69K Sell
2,485
-72
-3% -$191 ﹤0.01% 359
2023
Q1 		$6.21K Buy
2,557
+639
+33% +$1.46K ﹤0.01% 344
2022
Q4 		$3.66K Buy
1,918
+199
+12% +$423 ﹤0.01% 334
2022
Q3 		$4K Buy
+1,719
New +$4.76K ﹤0.01% 304

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

China Universal Asset Management Company's LXRX Position: Q4 2025 in Review

China Universal Asset Management Company sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2025, closing a stake of 63,698 shares — an estimated $86K sold.

China Universal Asset Management Company first reported a position in LXRX in Q3 2022 and held it in 13 quarters. The position peaked at $113K in Q1 2024. 125 funds tracked by Wall St. Rank hold LXRX as of Q4 2025.

  • China Universal Asset Management Company reported no remaining Lexicon Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 63,698 Lexicon Pharmaceuticals shares in Q4 2025, an estimated $86K.
  • China Universal Asset Management Company first reported a position in Lexicon Pharmaceuticals in Q3 2022 and held it in 13 quarters.
  • China Universal Asset Management Company's Lexicon Pharmaceuticals position peaked at $113K in Q1 2024.
  • 125 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2025.

Based on China Universal Asset Management Company's 13F filing for Q4 2025, filed 29 Jan 2026.